Prudential PLC Athersys, Inc Transaction History

Prudential PLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 13, 2020	SELL	$1.16 - $1.42 $4.89 Million - $5.99 Million	-4,217,697 Closed	0 $0
Q3 2019 Nov 13, 2019	SELL	$1.21 - $1.65 $6,534 - $8,910	-5,400 Reduced 0.13%	4,217,697 $4.22 Million
Q2 2019 Aug 14, 2019	BUY	$1.39 - $2.03 $15,567 - $22,735	11,200 Added 0.27%	4,223,097 $8.45 Million
Q3 2018 Nov 14, 2018	BUY	$1.86 - $2.18 $22,128 - $25,935	11,897 Added 0.28%	4,211,897 $8.85 Million
Q2 2018 Aug 14, 2018	SELL	$1.76 - $2.79 $616,000 - $976,500	-350,000 Reduced 7.69%	4,200,000 $8.27 Million
Q4 2017 Feb 14, 2018	SELL	$1.65 - $2.45 $99,151 - $147,225	-60,092 Reduced 1.3%	4,550,000 $8.24 Million
Q3 2017 Nov 14, 2017	SELL	$1.5 - $2.55 $764,862 - $1.3 Million	-509,908 Reduced 9.96%	4,610,092 $9.5 Million
Q2 2017 Aug 14, 2017	BUY	N/A	5,120,000	5,120,000 $7.73 Million

Ticker ATHX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 305,110,016
Market Cap $3.05M
Description
Athersys, Inc., a biotechnology company, focuses on the research and development activities in the field of regenerative medicine. Its clinical development programs are focused on treating neurological conditions, cardiovascular diseases, inflammatory and immune disorders, and pulmonary and other conditions. The company's lead platform product i...

Get notified when there are updates to the investment portfolio of Prudential PLC, based on Form 13F filings with the SEC.

Stay updated on Prudential PLC with notifications on news.